Dopamine D3 Receptor Neurons

Dopamine D3 Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Dopamine D3 Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Dopamine Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Ventral striatum, nucleus accumbens, islands of Calleja</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>D3 dopamine receptor (DRD3)</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gi/o-coupled, cAMP inhibition</td>
</tr>
<tr>
<td class="label">Expression Pattern</td>
<td>Limbic-preferential</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
</table>

Dopamine D3 Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Neurons expressing dopamine D3 receptors (D3R) are primarily located in limbic regions of the brain and play crucial roles in reward processing, motivation, emotional regulation, and cognitive function. The D3R has attracted significant interest as a therapeutic target for Parkinson's disease, schizophrenia, and drug addiction due to its unique pharmacological profile and distribution pattern. [@bourne2001]

Dopamine D3 Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Dopamine D3 Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Dopamine Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Ventral striatum, nucleus accumbens, islands of Calleja</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>D3 dopamine receptor (DRD3)</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gi/o-coupled, cAMP inhibition</td>
</tr>
<tr>
<td class="label">Expression Pattern</td>
<td>Limbic-preferential</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
</table>

Dopamine D3 Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Neurons expressing dopamine D3 receptors (D3R) are primarily located in limbic regions of the brain and play crucial roles in reward processing, motivation, emotional regulation, and cognitive function. The D3R has attracted significant interest as a therapeutic target for Parkinson's disease, schizophrenia, and drug addiction due to its unique pharmacological profile and distribution pattern. [@bourne2001]

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Molecular Biology

Gene and Protein

• Gene: DRD3 (Dopamine Receptor D3)
• Protein: 400 amino acids, 7-transmembrane GPCR
• Chromosome: 3q13.3
• Splice Variants: Multiple isoforms identified

Receptor Structure

• Topology: 7 transmembrane domains
• Extracellular loops: Ligand binding
• Intracellular loops: G protein coupling
• C-terminal tail: Phosphorylation sites

Signal Transduction

• Primary: Gi/o → inhibition of adenylyl cyclase
• cAMP: Reduced intracellular cAMP levels
• Downstream: PKA inhibition, DARPP-32 effects
• Other: PI3K/Akt, MAPK pathways

Receptor Pharmacology

• Agonists: Pramipexole, ropinirole, rotigotine
• Antagonists: Naftopidil, SB-277011-A
• Partial agonists: Cariprazine
• Selective ligands: High D3R selectivity available

Distribution in the Brain

Limbic System

• Nucleus accumbens shell: Highest D3R density
• Islands of Calleja: Dense expression
• Olfactory tubercle: Moderate expression
• Septal nuclei: Some expression

Basal Ganglia

• Ventral striatum: D3R > D2R in shell
• Striatum: Lower than D2R
• Globus pallidus: External segment
• Substantia nigra pars compacta: Some expression

Cortex

• Prefrontal cortex: Layer I, polymorphic layer
• Cingulate cortex: Anterior cingulate
• Entorhinal cortex: Temporal lobe

Other Regions

• Hippocampus: CA1 region
• Amygdala: Central nucleus
• Hypothalamus: Limited expression
• Thalamus: Paraventricular nucleus

Functional Roles

Reward Processing

• Reward motivation: D3R in motivational states
• Reward prediction: Error signals
• Reinforcement: Drug-seeking behavior
• Natural rewards: Food, sex, social interaction

Emotional Regulation

• Mood: D3R dysfunction in depression
• Anxiety: Anxiolytic effects of D3R blockade
• Stress response: HPA axis modulation
• Emotional memory: Amygdala involvement

Motivation and Drive

• Approach motivation: Incentive salience
• Behavioral activation: Psychomotor function
• Effort-based decisions: Cost-benefit analysis
• Anhedonia: D3R overactivity

Cognitive Functions

• Working memory: Prefrontal cortex
• Attention: Sustained attention
• Cognitive flexibility: Set-shifting
• Executive function: Planning and organization

Motor Control

• Modulatory role: Less direct than D1/D2
• Motor learning: Skill acquisition
• Habit formation: Dorsal striatum involvement

Neurodegeneration Relevance

Parkinson's Disease

• D3R expression: Upregulation in PD putamen
• Motor complications: D3R in levodopa-induced dyskinesia
• Pramipexole effects: D3R agonist therapy
• Non-motor symptoms: D3R in depression, anxiety
• Restless legs syndrome: D3R involvement
• Impulse control disorders: D3R agonist link

Schizophrenia

• D3R hypothesis: Enhanced D3R signaling
• Negative symptoms: Cognitive and emotional deficits
• Antipsychotic binding: D3R antagonism
• Cognitive enhancement: D3R blockade
• Treatment: Cariprazine (D3R partial agonist)

Drug Addiction

• D3R upregulation: With chronic drug exposure
• Cocaine seeking: D3R in relapse
• Alcohol use: D3R modulation
• Nicotine dependence: D3R involvement
• Opioid addiction: D3R in reward circuitry
• Therapeutic target: D3R antagonists in development

Alzheimer's Disease

• Cognitive decline: D3R in memory
• Amyloid effects: Aβ on D3R signaling
• Neuroprotection: D3R agonists being studied
• Mood symptoms: D3R in depression

Huntington's Disease

• Striatal D3R: Altered expression
• Motor symptoms: D3R contribution
• Psychiatric symptoms: Depression, anxiety
• Therapeutic potential: D3R modulators

Bipolar Disorder

• Mania: D3R involvement
• Depression: D3R in depressive states
• Mood stabilization: D3R effects

Clinical Significance

Movement Disorders

• Parkinson's disease: D3R agonist therapy (pramipexole, ropinirole)
• Restless legs syndrome: D3R agonist efficacy
• Dyskinesia: D3R in levodopa-induced movements

Psychiatric Disorders

• Schizophrenia: D3R partial agonist (cariprazine)
• Depression: D3R antagonists
• Bipolar disorder: Mood stabilizer effects
• Addiction: D3R antagonists in trials

Therapeutic Approaches

• D3R agonists: Pramipexole, ropinirole, rotigotine
• D3R partial agonists: Cariprazine
• D3R antagonists: SB-277011-A, naftopidil
• Selective modulators: Bitopertin

Research Methods

Detection

• Immunohistochemistry: Anti-D3R antibodies
• In situ hybridization: DRD3 mRNA
• Radioligand binding: 3HPD-128907
• PET imaging: 11CPHNO

Functional Studies

• cAMP assays: Gi signaling measurement
• GTPγS binding: G protein activation
• Electrophysiology: Neuronal recordings
• Behavior: Reward-related tasks

Animal Models

• Knockout mice: DRD3-/- mice
• Transgenic models: Human DRD3 expression
• Viral vectors: Region-specific manipulation

Background

The study of Dopamine D3 Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [Allen Brain Atlas - DRD3 Expression](https://human.brain-map.org/microarray/search/show?search_term=DRD3)
• [IUPHAR Database - D3 Receptor](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=216)
• [UniProt - DRD3](https://www.uniprot.org/uniprot/P35462)
• [PDB - D3 Receptor Structure](https://www.rcsb.org/structure/7RE7)

Pathway Diagram

The following diagram shows the key molecular relationships involving Dopamine D3 Receptor Neurons discovered through SciDEX knowledge graph analysis: